Sector consensus Sionna Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-10 pm EDT			5-day change	1st Jan Change
37.89 ^USD	-2.57%		-6.42%	-7.90%

Mar. 02	Sionna Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 02	Sionna Therapeutics Inc maintains strong cash position with about $310.3 million in cash and cash equivalents, expected to fund operations into 2028	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
SIONNA THERAPEUTICS, INC.	49.11	+29.61%	9
LONZA GROUP AG	675.78	+31.22%	23
BEONE MEDICINES AG	408.2	+31.82%	26
CELLTRION, INC.	257,416.67	+28.9%	24
IQVIA HOLDINGS INC.	232.25	+38.79%	20
REVOLUTION MEDICINES, INC.	133.7	+38.65%	20
ASCENDIS PHARMA A/S	250.86	+22.65%	16
MEDPACE HOLDINGS, INC.	500.08	+1.33%	12
EUROFINS SCIENTIFIC SE	71.85	+11.99%	14
IONIS PHARMACEUTICALS, INC.	97.6	+29.84%	23
ABIVAX	121.82	+12.9%	7
PRAXIS PRECISION MEDICINES, INC.	629.24	+99.04%	17
BIO-TECHNE CORPORATION	73.64	+32.58%	11
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	197.64	+12.52%	14
QIAGEN N.V.	55.46	+35.64%	14
ICON PUBLIC LIMITED COMPANY	131.92	+23.51%	13
TEMPUS AI, INC.	75.43	+75.66%	14
PHARMARON BEIJING CO., LTD.	37.34	+20.03%	12
KYMERA THERAPEUTICS, INC.	119.14	+40.09%	21
Average	13,751.46	+32.46%	16
Weighted average by Cap.	26,605.28	+31.36%	19